Alx Oncology Holdings annual revenue
2018
2019
2020
2021
2022
2023
2024
2025
Alx Oncology Holdings Revenue Growth & History (ALXO)
Alx Oncology Holdings reported $0 in revenue for fiscal 2025.
View full Alx Oncology Holdings company overviewAlx Oncology Holdings annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $0 | $0 | — |
| 2024 | 2024-12-31 | $0 | $0 | — |
| 2023 | 2023-12-31 | $0 | $0 | — |
| 2022 | 2022-12-31 | $0 | $0 | — |
| 2021 | 2021-12-31 | $0 | −$1.2M | −100.00% |
| 2020 | 2020-12-31 | $1.2M | −$3.6M | −75.35% |
| 2019 | 2019-12-31 | $4.8M | $2.7M | +132.03% |
| 2018 | 2018-12-31 | $2.1M | — | — |
Alx Oncology Holdings quarterly revenue
Q2.19
Q3.19
Q1.20
Q2.20
Q3.20
Q4.20
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $0 | $0 | — |
| Q1 2026 | 2026-03-31 | $0 | — | — |
| Q4 2025 | 2025-12-31 | $0 | — | — |
| Q3 2025 | 2025-09-30 | $0 | — | — |
| Q2 2025 | 2025-06-30 | $0 | — | — |
| Q4 2020 | 2020-12-31 | $0 | — | — |
| Q3 2020 | 2020-09-30 | $0 | −$1.3M | −100.00% |
| Q2 2020 | 2020-06-30 | $527,000 | −$768,000 | −59.31% |
| Q1 2020 | 2020-03-31 | $655,000 | — | — |
| Q3 2019 | 2019-09-30 | $1.3M | — | — |
| Q2 2019 | 2019-06-30 | $1.3M | — | — |
Alx Oncology Holdings revenue growth trends
Alx Oncology Holdings's latest reported quarter, Q2 2026, generated $0 in revenue.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Alx Oncology Holdings source filings ↗